Lpath retains Agility Clinical to serve as its primary CRO

Carlsbadm CA – Oct 8, 2013 – In a regulatory filing, Lpath (LPTN) also announced that it has retained Agility Clinical to serve as its primary contract research organization, CRO, for the remainder of the Nexus Trial. Read more here.

2016-06-28T11:59:15+00:00